New strategies in the management of retinoblastoma;Nouvelles stratégies dans le traitement du rétinoblastome

Journal Francais d'Ophtalmologie

Volumn 25, Issue 2, 2002, Pages 187-193

  Balmer, Aubin ^a   Munier, F ^a   Zografos, L ^a  

^a HÔPITAL OPHTALMIQUE JULES GONIN   (Switzerland)

Author keywords

Chemotherapy; Radiotherapy; Retinoblastoma; Thermochemotherapy; Thermotherapy

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; CARBOPLATIN; COBALT 60; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETOPOSIDE; HYDROXYAPATITE; PHOTOSENSITIZING AGENT; POLY(METHYL METHACRYLATE); POLYETHYLENE; TRETAMINE; VINCRISTINE;

BRACHYTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILDHOOD CANCER; CLINICAL TRIAL; CRYOCOAGULATION; DRUG EFFICACY; ENUCLEATION; GENE THERAPY; HUMAN; HYPERTHERMIC THERAPY; IMMUNOSUPPRESSIVE TREATMENT; LASER COAGULATION; MULTIDRUG RESISTANCE; PHOTODYNAMIC THERAPY; PROTON RADIATION; RETINOBLASTOMA; REVIEW; VISUAL PROSTHESIS;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; ETOPOSIDE; EYE ENUCLEATION; EYE, ARTIFICIAL; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FORECASTING; GENE THERAPY; HUMANS; HYPERTHERMIA, INDUCED; INFANT; INFANT, NEWBORN; MALE; NEOADJUVANT THERAPY; RETINAL NEOPLASMS; RETINOBLASTOMA; TIME FACTORS;

EID: 17544402863     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Decreasing frequency of enucleation in patients with retinoblastoma
2. Recent developments in the management of retinoblastoma
3. Enucleation technique for children with retinoblastoma
4. Use of the hydroxyapatite ocular implant in the pediatric population
5. Extrusion of porous polyethylene orbital implant in recurrent retinoblastoma
6. Postcontrast magnetic resonance imaging assessment of porous polyethylene orbital implant (Medpor)
7. Complications associated with pegging hydroxyapatite orbital implants
8. Problems with the hydroxyapatite orbital implant: Experience with 250 consecutive cases
9. Exposure of primary orbital implants in postenucleation retinoblastoma patients
10. Exposure of primary orbital implants in postenucleation retinoblastoma patients
11. Hypofractionation in retinoblastoma: An increased risk of retinopathy
12. External beam radiotherapy for retinoblastoma: I. Whole eye technique
13. External beam radiation therapy and retinoblastoma: Long-term results in the comparison of two techniques
14. External beam radiotherapy in retinoblastoma: Tumor control and comparison of 2 techniques
15. The focal treatment of retinoblastoma with emphasis on xenon arc photocoagulation
16. Plaque radiotherapy in the management of retinoblastoma. Use as a primary and secondary treatment
17. Second primary neoplasms in patients with retinoblastoma
18. Chemotherapy for retinoblastoma: Where do we go from here?
19. Mortality from second tumors among long-term survivors of retinoblastoma
20. Ocular complications after external beam radiotherapy for retinoblastoma
21. Late effects of radiation on the eye and ocular adnexa
22. Long-term treatment effects in patients with bilateral retinoblastoma: Ocular and mid-facial findings
23. A new era for the treatment of retinoblastoma
24. New treatment modalities for retinoblastoma
25. The outcome of chemoreduction treatment in patients with Reese-Ellsworth group V retinoblastoma
26. Le traitement actuel du rétinoblastome. 153 Enfants traités entre 1995 et 1998
27. Les tumeurs en ophtalmopédiatrie. Diagnostic et stratégie thérapeutique
28. Aktuelle therapieaspekte intraokularer tumoren
29. Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma
30. Chemotherapy plus local treatment in the management of intraocular retinoblastoma
31. Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy
32. First-line chemotherapy with local treatment can prevent external-beam irradiation and enucleation in low-stage intraocular retinoblastoma
33. Chemoreduction in the initial management of intraocular retinoblastoma
34. Thermotherapy for retinoblastoma
35. Role of chemotherapy alone or in combination with hyperthermia in the primary treatment of intraocular retinoblastoma: Preliminary results
36. Chemosensitivity and multidrug resistance to antineoplastic drugs in retinoblastoma cell lines
37. Multidrug-resistant phenotype in retinoblastoma correlates with P-glycoprotein expression
38. RAC nixes plan to treat retinoblastoma
39. An experimental application of gene therapy for human retinoblastoma
40. Subconjunctival carboplatin in retinoblastoma: Impact of tumor burden and dose schedule
41. A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma
42. Subconjunctival carboplatin therapy and cryotherapy in the treatment of transgenic murine retinoblastoma
43. Study on conservative treatment of retinoblastoma - Effect of intravitreal injection of melphalan on the rabbit retina
44. Iontophoretic delivery of carboplatin: Evaluation of pharmacokinetics and efficacy
45. Japanese contributions to ocular oncology
46. Local carboplatin and radiation therapy in the treatment of murine transgenic retinoblastoma
47. Hyperthermia in the treatment of intraocular tumors, in particular retinoblastoma
48. Retinoblastoma
49. Le traitement du rétinoblastome par protons accélérés